The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers

AAPS PharmSciTech

Volumn 5, Issue 1, 2004, Pages

  Smyth, Hugh D C ^a   Beck, Vance P ^b   Williams, Dennis ^a   Hickey, Anthony J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aerosol; Cascade impaction; Fine particle fraction; HFA134a; Laser diffraction

Indexed keywords

CHLOROFLUOROCARBON; FLUORESCENT DYE; NORFLURANE; PROPELLANT;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; IN VITRO STUDY; INHALATION SPACER; LASER DIFFRACTION; METERED DOSE INHALER; PARTICLE SIZE; VAPOR PRESSURE; AEROSOL; CHEMISTRY; EVALUATION; HUMAN;

AEROSOL PROPELLANTS; AEROSOLS; CHEMISTRY, PHARMACEUTICAL; CHLOROFLUOROCARBONS; HUMANS; METERED DOSE INHALERS; PARTICLE SIZE;

EID: 23144462418     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1007/bf02830575     Document Type: Article

References (25)

1. Williams RO, Patel AM, Barron MK, Rogers TL. Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from pMDI. Drug Dev Ind Pharm. 2001;27:401-412.
2. Everard ML. CFC transition: the Emperor's new clothes. Each class of drug deserves a delivery system that meets its own requirements. Thorax. 2000;55:811-814.
3. Crompton GK. The adult patient's difficulties with inhalers. Lung. 1990;168(suppl):658-662.
4. Wilkes W, Fink J, Dhand R. Selecting an accessory device with a metered-dose inhaler: variable influence of accessory devices on fine particle dose, throat deposition, and drug delivery with asynchronous actuation from a metered-dose inhaler. J Aerosol Med. 2001;14:351-360.
5. Berg E. In vitro properties of pressurized metered dose inhalers with and without spacer devices. J Aerosol Med. 1995;8(suppl 3):S3-S10; discussion S11.
6. Ellepola AN, Samaranayake LP. Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis. 2001;7:211-216.
7. Johnson DH, Robart P. Inhaler technique of outpatients in the home. Respir Care. 2000;45:1182-1187.
8. Williams RO III, Patel AM, Barron MK, Rogers TL. Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI. Drug Dev Ind Pharm. 2001;27:401-412.
9. Tobin MJ, Jenouri G, Danta I, Kim C, Watson H, Sackner MA. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am Rev Respir Dis. 1982;126:670-675.
10. Newman SP, Pavia D, Clarke SW. Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med. 1980;73:776-779.
11. Dubus JC, Guillot C, Badier M. Electrostatic charge on spacer devices and salbutamol response in young children. Int J Pharm. 2003;261(1-2):159-164.
12. Woodcock A, Acerbi D, Poli G. Modulite technology: pharmacodynamic and pharmacokinetic implications. Respir Med. 2002;96(suppl D):S9-S15.
13. Hirst PH, Pitcairn GR, Richards JC, Rohatagi S, Gillen MS, Newman SP. Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler. J Aerosol Med. 2001;14:155-165.
14. Barry PW, O'Callaghan C. In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices. Eur Respir J. 1997;10:1345-1348.
15. Smyth HDC, Hickey AJ. Multimodal particle size distributions emitted from HFA 134a solution pressurized metered dose inhalers. AAPS PharmSciTech. 2003;4: Article 38.
16. Thiel CG. Can in vitro particle size measurements be used to predict pulmonary deposition of aerosol from inhalers? J Aerosol Med. 1998;11:S43-S52.
17. Smyth HDC, Mejia-Millan EA, Hickey AJ. The effect of ethanol on solvency vapor pressure, and emitted droplet size of solution metered dose inhalers containing HFA 134a. Respir Drug Delivery VIII. 2002;2:735-738.
18. Smyth HDC, Hickey AJ. Comparative particle size analysis of solution propellant driven metered dose inhalers using cascade impaction and laser diffraction. Respir. Drug Delivery VIII. 2002;2:731-734.
19. Dewsbury NJ, Kenyon CJ, Newman SP. Effect of handling techniques on electrostatic charge on spacer devices: correlation with in vitro particle size analysis. Int J Pharm. 1996;137:261-264.
20. Dunbar CA, Hickey AJ. Evaluation of probability density functions to approximate particle size distributions of representative pharmaceutical aerosols. J Aerosol Sci. 2000;31:813-831.
21. Dunbar CA, Watkins AP, Miller JF. An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques. J Aerosol Med. 1997;10:351-368.
22. Dunbar CA, Watkins AP, Miller JF. Theoretical investigation of the spray from a pressurized metered-dose inhaler. Atomization Sprays. 1997;7:417-436.
23. Hinds WC. Aerosol technology: properties, behavior, and measurement of airborne particles. 2nd ed. New York, NY: Wiley; 1999.
24. Janssens HM, Devadason SG, Hop WC, LeSouef PN, De Jongste JC, Tiddens HA. Variability of aerosol delivery via spacer devices in young asthmatic children in daily life. Eur Respir J. 1999;13:787-791.
25. Ad Hoc Committee on Health Literacy for the Council of Scientific Affairs AMA. Health Literacy: report of the Council of Scientific Affairs. JAMA. 1999;281:552-557.